Literature DB >> 19021276

Carotid endarterectomy with simultaneous retrograde common carotid artery stenting: technical considerations.

Hernan A Bazan1, Malachi Sheahan, Alan Dardik.   

Abstract

Carotid endarterectomy with simultaneous retrograde common carotid artery stenting (CEA-RCCAS) is performed with increasing frequency to treat tandem common and internal carotid artery stenoses. Technical details are not clearly delineated in the literature. Our procedure aims to maximize procedural ease and cerebral protection. Although the need for the endovascular component being performed first, followed by shunt placement, and the use of short wires and sheaths has been advocated, we describe the avoidance of shunt placement and the use of long sheaths to facilitate the procedure using local anesthesia and cervical blockade. Use of local anesthesia, avoidance of a shunt, and use of a long sheath may increase the procedural applicability and safety in some patients. CEA-RCCAS permits safe simultaneous treatment of tandem common and internal carotid artery stenoses. The use of technical adjuncts described here will permit further expansion of the procedure to allow additional patients to be treated in this hybrid fashion. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 19021276     DOI: 10.1002/ccd.21730

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  2 in total

1.  Preliminary application of hybrid operation in the treatment of carotid artery stenosis in patients with complex ischemic cerebrovascular diseases.

Authors:  Liyong Zhang; Tao Xing; Fenyang Geng; Lixin Du; Jiyue Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

2.  Endovascular Stenting of Tandem Carotid Artery Origin and Bifurcation Stenotic Lesions Using Flow Reversal.

Authors:  Andrew A Fanous; Parham Yashar; Ashish Sonig; Amanda Zakeri; Kenneth V Snyder; Elad I Levy; Jason M Davies; Adnan H Siddiqui
Journal:  J Vasc Interv Neurol       Date:  2017-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.